March 3, 2022
Life Sciences
  • A new study found that a booster shot of either the Pfizer Inc.-BioNTech SE or Moderna Inc. COVID-19 vaccines restored protection against symptomatic sickness caused by the omicron variant. However, just two doses of either vaccine brand were only minimally effective: Pfizer vaccine’s effectiveness in blocking symptomatic disease dropped from 65 percent to 8 percent six months following the second dose, while Moderna’s vaccine had a 71 percent to 15 percent drop. (Article here)